Related Experiment Video
Updated: May 12, 2026
12:45
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Systematic review: cardiac resynchronization in patients with symptomatic heart failure
Finlay A McAlister1, Justin A Ezekowitz, Natasha Wiebe
1The University of Alberta and Capital Health Evidence-based Practice Center, Edmonton, Alberta, Canada. Finlay.McAlister@ualberta.ca
Annals of Internal Medicine
|September 9, 2004
Summary
Cardiac resynchronization therapy (CRT) significantly improves heart function, quality of life, and survival in advanced heart failure patients. This therapy reduces hospitalizations and mortality, offering a vital treatment option for selected individuals.
Area of Science:
- Cardiology
- Medical Devices
- Clinical Trials
Background:
- Symptomatic heart failure, despite optimal pharmacotherapy, is linked to significant patient morbidity and mortality.
- Advanced systolic heart failure presents ongoing challenges in patient management and outcomes.
Purpose of the Study:
- To evaluate the efficacy and safety of cardiac resynchronization therapy (CRT) in adults diagnosed with advanced systolic heart failure.
- To determine the impact of CRT on key clinical outcomes and patient well-being.
Main Methods:
- Systematic review of randomized controlled trials for efficacy and controlled trials plus prospective cohort studies for safety.
- Comprehensive literature search across multiple databases (Cochrane, MEDLINE, EMBASE) and FDA reports.
- Independent data extraction and analysis using random-effects models.
Main Results:
- CRT improved ejection fraction, quality of life, and functional status (NYHA class) in patients with reduced ejection fraction and prolonged QRS duration.
- A significant reduction in heart failure hospitalizations (32%) and all-cause mortality (21%) was observed, particularly in NYHA class III/IV patients.
- Implant success rate was high (90%), with low rates of peri-procedural mortality; however, lead dislodgement (9%) and device malfunctions (7%) were noted during follow-up.
Conclusions:
- Cardiac resynchronization therapy is effective in selected heart failure patients, improving hemodynamic status and reducing mortality.
- Benefits are most pronounced in patients with NYHA class III or IV symptoms, reduced ejection fraction, and prolonged QRS duration.
- Further research is needed to clarify CRT's role in patients with bradyarrhythmias or atrial fibrillation.
Related Concept Videos
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...